Furthermore, myo-Ins is also effective in normalizing ovarian function and improving oocyte and embryo quality in PCOS women who undergo assisted reproductive treatments, namely by increasing the ovary sensitivity to endocrine stimulation and reducing the doses of FSH administered to induce ovulation [56,57]. Here, BRD2 is linked to polycystic ovary syndrome.